Bonus BioGroup Ltd. (TLV:BONS)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
33.00
-0.90 (-2.65%)
Jun 10, 2026, 5:26 PM IDT
Market Cap385.48M +67.5%
Revenue (ttm)n/a
Net Income-24.49M
EPS-0.02
Shares Out 1.17B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,972,338
Open33.90
Previous Close33.90
Day's Range30.00 - 35.90
52-Week Range19.30 - 60.90
Beta0.78
Analystsn/a
Price Targetn/a
Earnings DateJun 12, 2026

About Bonus BioGroup

Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company’s products under development include BonoFill for the treatment of bone tissue regeneration in maxillofacial and orthopedic indications, and defects in limb and jaw bones which is in Phase II clinical trial, as well as in a preclinical stage for the treatment of bone augmentation in osteoporosis patients. It also develops MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS which is ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1981
Employees 42
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol BONS
Full Company Profile

Financial Performance

Financial Statements